Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Understand the reasons why investing is often considered a superior choice to saving for future financial goals. Take charge of your finances.
27,503 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Tuesday’s market action centers on fresh analyst calls for Albemarle, Booz Allen Hamilton, Cigna, DT Midstream, GE Ve...
Global markets weigh climate risk as a likely Super El Niño could boost temperatures in 2027. This stock trader’s gui...
Public safety officers can tap 457(b) funds penalty-free after leaving service, potentially enabling early retirement...
Chevron announces a quarterly dividend of $1.78 per share, marking 39 years of uninterrupted growth. Q4 results show ...
A sweeping market update is arriving just as tech stocks face a new mix of opportunities and risks. This arguably mos...
An anonymized NFL family real estate move in Chico, California sold for about $1.68 million, signaling ongoing demand...
Bezos pivots from ecommerce to the physical economy, aiming at a $70 trillion market that spans manufacturing, drug d...
London-based Fleek lands $25 million in a Series B to grow its network of vintage wholesalers and U.S./EU retailers. ...
A major fund recently trimmed its Centrus Energy stake, sending ripples through the market. This article breaks down ...
What would it look like if a legendary duo concentrated nearly $80 billion into one stock? This thought-provoking pie...
The Pentagon says commercial data was used to target U.S. service members, a development that could spur tighter data...